-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721.P1.50 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster I

Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Ekaterina Proskuriakova, MD1, Elisa Zucchetti, MD2*, Karen Sweiss, PharmD3, Nadim Mahmud, MBBS, PhD4, Matthew Koshy, MD5*, Damiano Rondelli, MD6* and Santosh L. Saraf, MD7

1Mount Sinai Hospital, Chicago, IL
2University of Illinois Chicago, Chicago
3Department of Pharmacy Practice, University of Illinois at Chicago, Hinsdale, IL
4Section of Hematology/Oncology, Department of Medicine, Univ. of Illinois at Chicago, Chicago, IL
5Department of Radiation Oncology, University of Illinois at Chicago, Chicago, IL
6Division of Hematology/Oncology, University of Illinois College of Medicine, Chicago, IL
7Department of Medicine, University of Illinois College of Medicine, Willowbrook, IL

Muhammad Umair Mushtaq1,2,3, Amir Kasaeian1,3*, Sibgha Gull Chaudhary, MD1,2,3*, Muhammad Kashif Amin, MD1,2,3*, Hediyeh Alemi1,3*, Naghmeh Khavandgar1,3*, Iqra Anwar, MBBS1,3*, Ahmad Basharat, MD1,3*, Matthew McGuirk1,3*, Peiman Hematti, MD3,4, Al-Ola Abdallah, MD1,2,3, Anurag K. Singh, MD1,2,3, Mehdi Hamadani, MD3,5, Joseph P. McGuirk, DO1,2,3 and Moazzam Shahzad, MD3,6

1Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
3Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
4Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
5Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
6Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL

Jamila Mammadova, MD1*, Yanina Pasikhova2*, Jongphil Kim, PhD3*, Junmin Whiting4*, Farhad Khimani, MD5*, Michael D. Jain, MD, PhD6, Sayeef Mirza, MD, MPH6,7, Rawan Faramand, MD6, Julio C. Chavez, MD8, Bijal D Shah, MD6, Olga Klinkova, MD, MS9*, Aliyah Baluch, MD9*, Jose L. Ochoa-Bayona, MD2*, Fabiana Perna, MD, PhD10, Taiga Nishihori, MD2, Nelli Bejanyan, MD5, Frederick Locke, MD6 and Aleksandr Lazaryan, MD, MPH, PhD5

1Vanderbilt University Medical Center, Nashville, TN
2Moffitt Cancer Center, Tampa, FL
3Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL
5Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
6Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
7H. Lee Moffitt Cancer Center and Research Institute, Tampa
8Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
9Department of Infectious Diseases, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
10Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Noah Merin, MD, PhD1, Haein Kim2*, Yuliya Linhares, MD3*, Akil Merchant, MD4, Justin M. Darrah, MD5, Joshua Sasine, MD5, Hannah Lee, MD6, Robert Allen Vescio, MD2, David Oveisi, MD2*, Brittany McGalliard7*, Ali Rejali5*, Patricia VanStrien5*, Ellen B. Klapper, MD8*, Behrooz Hakimian6*, John Chute, MD5* and Ronald Paquette, MD9

1Hematology and Cellular Therapy, Cedars-Sinai Medical Center, Los Angeles, CA
2Division of Hematology and Cellular Therapy, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA
3Miami Cancer Institute at Baptist Health, Inc., Miami, FL
4Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA
5Cedars-Sinai Medical Center, Los Angeles, CA
6Cedars-Sinai, Los Angeles, CA
7Department of Pharmacy, Cedars-Sinai Medical Center, Los Angeles, CA
8Transfusion Medicine, Cedars Sinai Medical Center, Los Angeles, CA
9Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA

Marta Peña1*, Lorenzo Lazzari2*, Diego Fernando Martinez Moreno, MD3*, Fabio Ciceri, MD4*, Aitana Balaguer Rosello, MD, PhD5*, Jaime Sanz6*, Maria Jesus Pascual7*, Ana Benzaquen, MD8*, Jose Luis Piñana, MD, PhD9*, Felipe Peña, MD10*, Maria Queralt Salas11*, Agustin Nieto12*, Ignacio Español13*, Maria huguet Mas, MD14*, Leyre Bento De Miguel15*, Adolfo Jesús Sáez Marín, MD16*, Pere Barba, MD17, Silvia Filaferro18*, Alberto Mussetti19* and Raffaella Greco, MD20*

1Institut Català D'Oncologia, L'Hospitalet De Llobregat, Spain
2Hematology Department - *cofirst author, IRCCS Ospedale San Raffaele, Milano, ITA
3Hematology Department, Clinica IMAT - AUNA, Montería, Colombia
4Hematology and Bone Marrow Transplantation Unit, I.R.C.C.S. San Raffaele Scientific Institute, Milan, Italy
5Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
6Hematology Department, Hospital Universitari i Politècnic La Fe, Departament de Medicina Universitat de Valencia, CIBERONC, Instituto Carlos III, Spain, VALENCIA, Spain
7Hospital Regional Universitario de Málaga, Malaga, Spain
8Hospital Clínico Universitario-INCLIVA, Valencia, Spain
9Servicio de Hematología, Hospital Clínico Universitario de Valencia, Valencia, Spain
10Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain
11Hospital Clínic de Barcelona, Barcelona, Spain
12Department of Hematology, Complexo Hospitalario de Vigo - Hospital Álvaro Cunqueiro, Vigo, Spain
13Hematology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
14Hematology Department, Institut Català d'Oncologia - Hospital German Trias i Pujol, Barcelona, Spain
15Hematology Department, Son Espases University Hospital, IdISBa, Palma, Spain
16University of Complutense, Hospital 12 de Octubre, Madrid, Spain
17Deparment of Hematology, Vall Hebron Institute of Oncology (VHIO), Hospital Universitari Vall D'Hebron, La Garriga, Barcelona, Spain
18Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular (GETH-TC) Data Office, Madrid, Spain
19Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain
20Unit of Hematology and Stem Cell Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy

Gianluca Cavallaro1*, Chiara Pavoni2*, Alessandra Algarotti3*, Maria Caterina Micò4*, Anna Grassi2*, Federico Lussana5,6*, Maria Chiara Finazzi2*, Giuliana Rizzuto2*, Benedetta Rambaldi2*, Anna Salvi2*, Orietta Spinelli2* and Alessandro Rambaldi2,5

1Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Verdello, Italy
2Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
3Department of Oncology-Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy
4U.O.C. Ematologia, G.O.M. "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy
5Department of Oncology and Hematology, University of Milan, Milan, Italy
6Department of Oncology and Hematology, University of Milan and ASST Papa Giovanni XXIII, Bergamo, Italy

Xiaoning Wang, PhD1, Juan Ren, M.D2*, Huachao Zhu, M.D3*, Yuqi Wang, M.D4* and Pengcheng He5*

1Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'An, China
2hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
3The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
4The First Affiliated Hospital of Xi'an Jiaotong University, Xi'An, China
5Department of Hematology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China

Maria Queralt Salas, MD1*, Enric Cascos, MD2*, Estefanía Pérez López, MD3*, Mónica Baile González, MD4*, Carlos Martín-Rodriguez, MD5*, Maria Jesús Pascual, MD6*, Marta Luque, MD7*, Albert Esquirol, MD8*, Carmen Martin Calvo, MD9*, Felipe Peña, MD10*, Inmaculada Heras, MD11*, Adolfo Jesús Sáez Marín, MD12*, Itziar Oiartzabal Ormategui, MD13*, Sara Fernandez-Luis, MD14*, Juan Dominguez Garcia, MD15*, Sara Villar, MD16*, Miguel Fernandez de Sanmamed Girón, MD17*, Leslie González, MD18*, José Luis López Lorenzo, MD19*, Lucia García Mañó20*, Ana Pilar Gonzalez, MD21*, Tamara Torrado, MD22*, Silvia Filafferro23*, Pascual Balsalobre24*, Alberto López25*, Guillermo Orti, MD, PhD26* and Manuel Jurado Chacón27*

1Hematopoietic Transplantation Unit, Hospital Clinic de Barcelona, ICAMS, Barcelona, Spain
2Cardiology Department, Hospital Clinic de Barcelona, Barcelona, Spain
3Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
4Servicio de Hematología y Hemoterapia del Complejo Asistencial Universitario de Salamanca -IBSAL, Salamanca, Spain
5Hospital Clinico Universitario De Salamanca (CAUSA / IBSAL), Salamanca, ESP
6Hospital Regional de Málaga, Málaga, Spain
7Hospital Regional Universitario De MáLaga, Malaga, ESP
8Hematology and Hemotherapy Department, Hospital de la Sant Creu i Sant Pau. IIB-Sant Pau and José Carreras Leukemia Research Institutes. Universitat Autónoma de Barcelona, Barcelona, Spain
9Hospital Universitario Reina Sofía, Cordoba, Spain
10Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain
11Hematology Division, Hospital Morales Meseguer, Murcia, Spain
12University of Complutense, Hospital 12 de Octubre, Madrid, Spain
13Hematology Department, Hospital Universitario de Donosti, Donosti, Spain
14Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
15University Hospital MarquéS De Valdecilla - IDIVAL, Santander, Spain
16Hematology and Cell Therapy Department. Clinica Universidad de Navarra. IdiSNA., Pamplona, Spain
17Cardiology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Gran Canaria, Spain
18Hematology Department, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
19Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
20Hematology Department., Hospital Universitario Son Espases, IdISBa., Palma, Spain
21Hospital Universitario Central de Asturias, Oviedo, Spain
22Hospital Universitario de A Coruña, A Coruña, Spain
23Grupo EspañOl De Trasplante De Progenitores HematopoyéTicos Y Tera, Madrid, ESP
24Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular (GETH-TC) Data Office, Madrid, Spain
25Hematology Department, Fundación Jiménez Díaz, Madrid, Spain
26Vall D' Hebron University Hospital, Barcelona, Spain
27Hospital Univ. Virgen de las Nieves, Granada, Spain

Rui MA1*, Xiaoyu Zhu2, Jianping Zhang3*, Jia Chen4*, Li Xuan5*, Hailong Yuan6*, Yang Cao7*, Weijie Cao, MD8*, Xiaosheng Fang9*, Kourong Miao10*, Xiaoxia Hu11*, Hai Yi, MD12*, Yanmin Zhao, MD13*, Yuanbin Wu14*, Ting Yang15*, Hongtao Wang16*, Yue Yin17*, Zhongming Zhang18*, Xiaojun Huang19 and Yuqian Sun19*

1Peking University People's Hospital, Peking University Institute of Hematology, BEIJING, VA, China
2Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
3Beijing Lu Daopei Hospital, Beijing, China
4National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
5Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
6The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
7Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
8Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
9Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
10People's Hospital of Jiangsu Province, Suzhou, China
11Ruijin Hospital, SHANGHAI, China
12Department of Hematology, The General Hospital of Western Theater Command, Chengdu, China
13Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
14Guangdong Hospital of Traditional Chinese Medicine, Guangzhou, China
15Department of Hematology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China
16Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China
17Peking University First Hospital, Beijing, China
18Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
19Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China

Mithra Lakshmi Narasimhan, MBBS, MD1, Irem Eldem, MD1, David B Wilson, MD, PhD1*, Ginny Schulz, PhD1*, Robert J Hayashi, MD1* and Shalini Shenoy, MD2

1Department of Pediatrics, Division of Hematology/Oncology, Washington University School of Medicine, St Louis, MO
2Department of Pediatrics, Division of Hematology / Oncology, Washington University School of Medicine, Saint Louis, MO

Brais Lamas Rodriguez1*, Marta Santiago, MD1*, Pedro Asensi1*, Aitana Balaguer Rosello, MD, PhD1*, Pedro Chorao, MD1*, Ana Belén Gálvez1*, Alessandro Liquori, PhD2*, Pilar Lloret1*, Juan Montoro, MD, PhD1*, Clara Sopeña Pell-Ilderton1*, Esperanza Such, PhD1*, Marta Villalba1*, Jose M. Fernández3*, Guillermo Sanz, MD, PhD1, José Cervera, MD, PhD1,4*, Pilar Solves1*, Jaime Sanz, MD, PhD1*, Javier de la Rubia1* and Inés Gómez Seguí, MD, PhD1*

1Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
2Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
3Pediatric Transplant Unit, Hospital Universitari i Politècnic La Fe, Valencia, Spain
4Genetics Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain

Bernd Gruhn1*, Dinah Walther1*, Jana Ernst, MD1* and Till Milde, MD1,2*

1Department of Pediatrics, Jena University Hospital, Jena, Germany
2Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany

Manuel Jorge Fernández Villalobos1*, Rebeca Bailen2*, Ignacio Alberto Gomez Centurion Luna3*, Pablo Silva4*, Lucia Castilla Garcia5*, Paula Fernández-Caldas6*, Sonia Alonso5*, Adriana Ahumada5*, Carlos Iniesta5*, Rafael Bañares5,7*, Ramon Garcia-Sanz, MD, PhD2,8 and Mi Kwon, MD, PhD9

1Department of Hematology, Hospital General Universitario Gregorio Marañon, Madrid, Spain
2General University Hospital Gregorio Marañón, Madrid, Spain
3Hospital General universitario Gregorio Marañon, MADRID, ESP
4Hematology Dpt., Hosp. Gen. Univ. Gregorio Marañón, Madrid, Spain
5Hospital General Universitario Gregorio Marañon, Madrid, Spain
6Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
7Instituto de Investigacion Sanitaria Gregorio Marañon, Madrid, Spain
8Health Research Institute Gregorio Marañón, Madrid, Spain
9Institute of Health Research Gregorio Marañon, Madrid, Spain

Tamara Leite1*, Nicole Janusz2,3*, Leanne Mortimer4*, Amanda Carroll1*, Natasha K. Kekre1,2,3, Michael Kennah2,3*, Nadia Sant1,2,3,4*, Austin Yan2,3*, Jaxon Senechal3*, Derek MacFadden1,2,3,4* and C. Arianne Buchan1,2,3*

1The Ottawa Hospital Research Institute (OHRI), Ottawa, Canada
2The Ottawa Hospital, Ottawa, Canada
3The University of Ottawa, Ottawa, Canada
4The Eastern Ontario Laboratory Association, Ottawa, Canada

Michael Daunov, DO1, John Sumodi2*, Nikki Agarwal, MD1*, Molly Megan Gallogly, MD, PhD1,3, Leland Metheny, MD1,3, Ben K. Tomlinson, MD1,3, Rebecca B. Klisovic, MD1,4, Ali W. Bseiso, MD1*, Brett Glotzbecker, MD1*, Kord Honda5* and Koen van Besien, MD, PhD1,3

1Department of Hematology and Stem Cell Transplant, University Hospitals Seidman Cancer Center, Cleveland, OH
2Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, OH
3Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
4Case Western Reserve University, Cleveland, OH
5Department of Dermatopathology, University Hospitals, Cleveland, OH

Claire Baniel1*, Natalie Park, BA2*, Daniella Klebaner, MD, MPH2*, William Shomali, MD3, Jason Gotlib, MD, MS4, Sally Arai, MD5, Susan Hiniker, MD2*, Richard T. Hoppe, MD6, Laura Johnston, MD5 and Michael S. Binkley, MD, MS6*

1Stanford School of Medicine, Stanford, CA
2Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA
3Department of Medicine, Division of Hematology, Stanford University School of Medicine, Los Altos, CA
4Stanford Cancer Institute, Stanford School of Medicine, Stanford, CA
5Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
6Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA

Gary Simmons1, Roy Sabo, PhD2*, Manjari Sriparna, MD3*, Cody McIntire3*, Elizabeth Krieger, MD4*, Alpha Fowler, MD5*, Catherine Roberts, PhD6* and Amir Ahmed Toor, MD3

1Virginia Oncology Associates, Norfolk, VA
2Massey Cancer Center, Virginia Commonwealth University, Richmond, VA
3Virginia Commonwealth University, Richmond, VA
4VCU, Richmond, VA
5Virginia Commonwealth University Medical Center, Richmond, VA
6Massey Cancer Center, Virginia Commonwelath University, Richmond, VA

Moazzam Shahzad, MD1,2, Aleenah Mohsin1,2*, Muhammad Kashif Amin, MD1,2,3*, Aqeeb Ur Rehman, MD1,2*, Sibgha Gull Chaudhary, MD1,2,3*, Iqra Anwar, MBBS1,2*, Matthew McGuirk1,2*, Mohammad Ammad Ud Din, MBBS4, Leyla O. Shune, MD2,3,5, Al-Ola Abdallah, MD1,2,3, Mehdi Hamadani, MD2,6, Joseph P. McGuirk, DO1,3 and Muhammad Umair Mushtaq1,3,7

1Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
2Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
3US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
4Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5University of Kansas Medical Center, Kansas City, KS
6Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
7MRF, Kansas City

Muhammad Umair Mushtaq1,2,3, Amir Kasaeian1,3*, Sibgha Gull Chaudhary, MD1,2,3*, Muhammad Kashif Amin, MD1,2,3*, Hediyeh Alemi1,3*, Naghmeh Khavandgar1,3*, Iqra Anwar, MBBS1,3*, Sohaib Irfan, MD1,3*, Matthew McGuirk1,3*, Al-Ola Abdallah, MD1,3, Anurag K. Singh, MD1,2,3, Mehdi Hamadani, MD3,4, Joseph P. McGuirk, DO1,2,3 and Moazzam Shahzad, MD3,5

1Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
3Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
4Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
5Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL

Shiyuan Wang, MD1*, Lipeng Liu2*, Yuanyuan Ren, MD3*, Xia Chen4*, Yang Wan, MD PhD2*, Xiaolan Li2*, Wenyu Yang1*, Ye Guo3*, Xiaofan Zhu, MD5 and Fang Liu, MD2*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences& Peking Union Medical College, Tianjin, China
2Department of Pediatric Hematology and Oncology, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences& Peking Union Medical College, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
4Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin, China
5State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC, Tianjin, China

Naoki Kurita, MD, PhD1*, Kazushi Maruo, PhD2*, Fumihiko Kimura, MD, PhD3, Yachiyo Kuwatsuka, MD PhD4*, Toshihiro Matsukawa, M.D., Ph.D.5*, Takaaki Konuma, MD, PhD6*, Shinichi Kobayashi, MD3, Mamiko Sakata-Yanagimoto1*, Noriko Doki7, Masatsugu Tanaka, MD8*, Naoyuki Uchida9, Tetsuya Nishida10*, Masashi Sawa11*, Yuta Hasegawa, MD, PhD12*, Hirohisa Nakamae, MD, PhD13*, Shuichi Ota, MD, PhD14, Makoto Onizuka15, Takahiro Fukuda16*, Fumihiko Ishimaru, MD, PhD17, Ken Tabuchi18*, Yoshiko Atsuta19*, Junya Kanda, MD, PhD20* and Hideki Nakasone, MD, PhD21

1Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
2Department of Biostatistics, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
3Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, JPN
4Nagoya University Hospital, Nagoya, Japan
5Department of Hematology, Hokkaido University Faculty of Medicine, Graduate School of Medicine, Sapporo, Japan
6Department of Hematology and Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
7Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
8Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
9Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations TORANOMON HOSPITAL, Tokyo, Japan
10Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan
11Department of Hematology and Oncology, Anjo Kosei Hospital, Anjyo, Japan
12Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan
13Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan
14Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan
15Department of Hematology/Oncology, Tokai University, Isehara, Japan
16Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
17Japanese Red Cross Blood Service Headquarters, Tokyo, Japan
18Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
19The Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
20Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
21Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan

Sibgha Gull Chaudhary, MD1,2,3*, Moazzam Shahzad, MD1,4, Kayla Pfannenstiell3*, Muhammad Kashif Amin, MD1,2,3*, Amir Kasaeian1,3,5*, Naghmeh Khavandgar1,3*, Hediyeh Alemi1,3*, Sohaib Irfan, MD1,3*, Matthew McGuirk2,3*, Syed Nasir Abbas Bukhari1,3*, Anurag K. Singh, MD1,2,3, Mehdi Hamadani, MD1,6 and Muhammad Umair Mushtaq1,2,3

1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
4Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
5Research Institute For Oncology, Hematology and Cell Therapy, Shariati Hospital,, Tehran, Massachusetts, IRN
6Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Zhongli Hu1,2*, Hai He3*, Shiqi Liu1,2*, Ying Dong4*, Zhiping Fan1,2*, Yiqing Li5*, Fen Huang1,2*, Na Xu1,2*, Can Liu6*, Yunxin Zeng7*, Ping Zhu8*, Ren Lin, PhD1,2*, Hua Jin2,9*, Xiong Zhang4*, Ruijuan Sun3*, Qifa Liu, MD1,2,3 and Li Xuan1,2*

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China
3Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, China
4Department of Hematology, Maoming People's Hospital, Maoming, China
5Department of Hematology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
6Department of Hematology, Hunan Provincial People's Hospital, Changsha, China
7Department of Hematology, the Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China
8Department of Hematology, the First People's Hospital of Chenzhou, Chenzhou, China
9Nanfang Hospital, Southern Medical University, Guangzhou, China

Issa F. Khouri, MD1, Hagop M. Kantarjian, MD2, Alison M. Gulbis, Pharm D3*, Manuel M. Christopher4*, Fadi G. Haddad, MD2, Hussein A. Abbas, MD, PhD2, Bofei Wang, PhD2, Koji Sasaki, MD2, Nitin Jain, MD2, Tapan M. Kadia, MD2, David Marin, MD1, Elizabeth J. Shpall, MD1, Gabriela Rondon, MD1, Hind Rafei, MD1, Jeremy Ramdial, MD1, Jin S. Im, MD, PhD1, Partow Kebriaei, MD1, Wei Qiao, PhD4*, Richard E. Champlin, MD1 and Elias Jabbour, MD2

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston
4Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX

Michael Haddadin, MBBS1, Adham Obedat, MD2*, Farah Al-Bitar, MD3*, Lori Maness, MD1, Krishna Gundabolu, MBBS4, Shyam Ajay Patel, MD, PhD5 and Vijaya Raj Bhatt, MD6

1Fred & Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE
2Department of internal medicine, Presbyterian Health Services, Albuquerque, NM
3Department of Pediatrics and Adolescent Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI
4Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center College of Medicine, Omaha, NE
5UMass Chan Medical School, Worcester, MA
6The Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE

Alessandra Picardi, MD1*, Monia Marchetti, MD, PhD2*, Luca Castagna3*, Mattia Algeri, MD4*, Stella Santarone, MD 5*, Marco Zecca, MD6*, Michele Malagola, MD7, Nicola Mordini8*, Franca Fagioli, MD, PhD9*, Angelo Michele Carella, MD10*, Raffaella Greco, MD11*, Francesco Onida, MD12, Domenico Pastore, MD13*, Michele Troiano14*, Anna Mussano15*, Federica Tangari16*, Gaspare Guglielmi17*, Adriana Balduzzi, MD18, Stefano Botti19*, Chiara Cannici20*, Martina Pitea21*, Fabio Ciceri, MD22*, Francesca Bonifazi23* and Massimo Martino, MD24*

1Stem Cell Transplant Program AORN Cardarelli, Naples and Biomedicine and Prevencion Department of Tor Vergata University, Rome, Naples / Rome, Italy
2Hematology & Transplant Unit, University Hospital SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
3Bone Marrow Transplantation Unit AOR Villa Sofia Cervello, Palermo, Italy
4Department of Hematology-Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
5Centro Trapianti Midollo Osseo; Azienda Sanitaria Locale di Pescara, Pescara, ITA
6Pediatric Hematology-Oncology,, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
7Clinical and Experimental Sciences, Brescia, BS, Italy
8Hematology, Azienda Ospedaliera S Croce e Carlo; Cuneo, Italy;, Cuneo, ITA
9Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin, Italy
10Hematology and Bone Marrow Transplant Unit, IRCCS Fondazione Casa Sollievo della Sofferenza San Giovanni Rotondo, Foggia, Italy, San Giovanni Rotondo, Italy
11Unit of Hematology and Stem Cell Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy
12Hematology and BMT Unit - ASST Fatebenefratelli-Sacco - University of Milan, Italy;, Milan, Italy
13Hematology and Bone Marrow Transplant Unit, Brindisi, Italy, Brindisi, Italy
14Fondazione Casa Sollievo Della Sofferenza IRCCS, Radioterapia - San Giovanni Rotondo, Foggia, ITALIA;, Foggia, Italy
15Responsabile SS Radioterapia S.Anna - O.I.R.M.- SC Radioterapia U Città della Salute e della Scienza – Torino, Italy, Torino, Italy
16Unit of Clinical Pharmacy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy;, Roma, Italy
17Pharmacy Unit, AORN Cardarelli, Naples, Italy;, Napoli, Italy
18Fondazione IRCCS San Gerardo dei Tintori, Pediatric Hematopoietic Stem Cell Transplant Unit, Monza, Italy
19Haematology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Reggio Emilia, Italy
20Hematology Unit, AO SS Antonio e Biagio e Cesare Arrigo di Alessandria, Alessandria, Italy, Alessandria, Italy
21Trials Office GITMO Gruppo Italiano per il Trapianto di Midollo Osseo, cellule staminali emopoietiche e terapia Cellulare, Bologna, Italy
22Hematology and Bone Marrow Transplantation Unit, I.R.C.C.S. San Raffaele Scientific Institute, Milan, Italy
23IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
24Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Stem Cell Transplant Program CIC 587, Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli”, Presidio Morelli, Viale Europa, 8, Reggio Calabria, Italy

Chen Liang*, Donglin Yang*, Yi He*, Aiming Pang*, Xiaohui Zheng*, Gang Li*, Mingzhe Han*, Erlie Jiang and Sizhou Feng*

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China

Yu-Cheng Bao1*, Xuan Cai2* and Xiao-Hui Zhang, MD, PhD1

1Peking University People’s Hospital, Beijing, China
2Peking University People's Hospital, Beijing, CHN

Sergi Camarillas, MD1,2*, Gilda Coralia Cetina Castro, BS3*, Alba Puyuelo, MD4*, Elisa Roldan, MD5*, Víctor Navarro Garces6*, Lorenzo Carita7*, Ana Perez Gonzalez, MD8*, Maria Sola, MD9,10,11*, Maria Laura Fox, MD2*, Félix López-Cadenas, MD12*, Pilar Verlarde13*, Guillermo Orti, MD, PhD14*, Antonio Garcia, MD15*, Anna Martín Carrizosa, MD16*, Marina Serra, MD17*, Olga Salamero, MD18,19* and David Valcarcel, MD, PhD20

1University Hospital Vall d’Hebron, Barcelona, Spain
2Vall d'Hebron University Hospital, Barcelona, Spain
3Department of Hematology. National Institute of Cancer, Ciudad de Méjico, Méjico, Ciudad de Méjico, Mexico
4Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
5Sheffield Teaching Hospitals NHS Foundation Trust. Sheffield, United Kingdom, Sheffield, United Kingdom
6Oncology Data Science (ODysSey), Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d’Hebron, Barcelona, Spain
7Statistic Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
8Vall d´Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebrón, Barcelona, Spain
9Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, University Autonoma of Barcelona (UAB), Barcelona, Spain
10Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
11Hematology Department, Vall d’Hebron University Hospital, University Autònoma of Barcelona (UAB), Barcelona, Spain
12Department of Hematology. Vall d'Hebron University Hospital, Barcelona, Spain., Barcelona, Spain
13Department of Hematology, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
14Vall D' Hebron University Hospital, Barcelona, Spain
15Hospital Arnau de Vilanova, Lleida, Spain
16Hematology Department, Hospital Universitario Vall d’Hebron, Barcelona, Spain
17Department of Hematology, Vall d'Hebron University Hospital, Barcelona, Spain
18Cooperative Group for the Study and Treatment of Acute and Myelodysplastic Leukemias (CETLAM), Barcelona, Spain
19Department of Hematology, Hospital Universitari Vall d'Hebron, Barcelona, ESP
20Department of Hematology, Vall d’Hebron Institute of Oncology, University Hospital Vall d’Hebron,, Barcelona, Spain

Jena Schmitz, DNP, APRN, FNP-C1, Eric Gaskill, PharmD1*, Samantha Price, PharmD1*, Biwei Cao, MS2*, Jongphil Kim, PhD2*, Aliyah Baluch, MD3*, Olga Klinkova, MD, MS3*, Rawan Faramand, MD1, Asmita Mishra, MD, MBA1, Lia Perez, MD1*, Farhad Khimani, MD1*, Aleksandr Lazaryan, MD, MPH, PhD1, Jose L. Ochoa-Bayona, MD4*, Hien Liu, MD4, Sayeef Mirza, MD, MPH1, Michael Nieder, MD1*, Claudio Anasetti, MD1*, Taiga Nishihori, MD1, Joseph A. Pidala, MD, PhD1, Nelli Bejanyan, MD1 and Hany Elmariah, MD, MS1

1Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Department of Infectious Diseases, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4Moffitt Cancer Center, Tampa, FL

Nikki Agarwal, MD1*, Pingfu Fu, PhD2*, Michael Daunov, DO1, Brenda W Cooper, MD1,2, Ben K. Tomlinson, MD1,2, Rebecca B. Klisovic, MD1, Marcos de Lima3*, Folashade Otegbeye, MBBChir, MPH4, Changchun Deng, MD, PhD1,2, Yeritza Hernandez-Collazo1*, Jignesh Dalal, MD1*, James Martin, MD1,2, Seunghee Margevicius2*, James J. Ignatz-Hoover, MD, PhD1*, Ok-Kyong Chaekal, MD1,2*, Molly Megan Gallogly, MD, PhD1,2, Koen van Besien, MD, PhD1,2 and Leland Metheny, MD1,2

1Department of Hematology and Stem Cell Transplant, University Hospitals Seidman Cancer Center, Cleveland, OH
2Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
3Ohio State University, Columbus, OH
4Fred Hutchinson Cancer Center, SEATTLE, OH

Carter Quinn1*, Raag Patel1*, Steven Boxer1*, Mohammad Nisar1*, Malek Moumne1*, Aditya Bhave1*, Anthony Elengickal1*, Megh Mehta1*, Danny Yakoub1* and Amany R. Keruakous2,3

1Medical College of Georgia, Augusta, GA
2Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, GA
3Georgia Cancer Center, Augusta University, Augusta, GA

Chuan Li1*, Danping Zhu1*, Jia Chen2*, Xiaoyu Zhu3, Nainong Li4, Weijie Cao, MD5*, Zhongming Zhang6*, Yehui Tan7*, Xiaoxia Hu8*, Hailong Yuan9*, Xiaosheng Fang10*, Yue Yin11*, Hongtao Wang12*, Nan Li13*, Xiao Jun Huang1 and Yuqian Sun1*

1Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
2The First Affiliated Hospital of Soochow University, Suzhou, China
3Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
4Hematopoietic Stem Cell Transplantation Center, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Department of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
5Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
6Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
7the first affiliated hospital of jilin university, Changchun, China
8Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
9The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
10Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
11Peking University First Hospital, Beijing, China
12Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China
13Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China

Huang Qiulin, PhD Candidate1*, Rongrong Liu, MD1,2,3*, Lianjin Liu1*, Meiqing Wu1*, Lingling Shi, MD1*, Gaohui Yang1*, Zhongming Zhang1*, Qifa Liu, MD4 and Yongrong Lai, MD1,2,3*

1Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
2Guangxi Key Laboratory of Thalassemia Research, Nanning, China
3NHC Key Laboratory of Thalassemia Medicine, Nanning, China
4Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China

*signifies non-member of ASH